
Abstract Background Adult trauma patients with refractory acute cardiopulmonary failure sufer from high morbidity and mortality. In the past decade, a growing body of researches has …
Background The role of intra-aortic balloon pump (IABP) combined with venoarterial extracorporeal membrane oxygenation (VA-ECMO) in patients with cardiogenic shock (CS) …
Intra-aortic balloon pump after VA-ECMO reduces mortality in …
Background The role of intra-aortic balloon pump (IABP) combined with venoarterial extracorporeal membrane oxygenation (VA-ECMO) in patients with cardiogenic shock (CS) …
The patient population treated with VV-ECMO is markedly heterogeneous, encompassing a wide range of etiologies and immune responses. This diversity con-trasts sharply with the …
Development and external validation of a machine learning model …
Background Patients supported by extracorporeal membrane oxygenation (ECMO) are at a high risk of brain injury, contributing to significant morbidity and mortality. This study aimed to …
Sep 30, 2016 · Background: Although many risk models have been tested in patients who undergo extracorporeal membrane oxygenation, few have been assessed for patients who …
Positive end-expiratory pressure management in patients with …
Aug 26, 2024 · The latter is particularly crucial for severe ARDS patients with right ventricular failure unresponsive to conservative treatments. In such cases, V-V ECMO can facilitate gas …
Prolonged time from intubation to cannulation in VV-ECMO for …
Nov 10, 2021 · Extrapolating data from H1N1 influenza pandemic, ELSO guidelines for VV-ECMO [1], consider a duration of mechanical ventilation exceeding 7 days as a relative major …
We read with great interest Staudacher et al.’s illustra-tive cases of beta-blocker therapy on V-V ECMO [1]. The authors’ excellent work reminds us not to focus on the easily measured arterial …
Neurological monitoring and management for adult …
Background Critical care of patients on extracorporeal membrane oxygenation (ECMO) with acute brain injury (ABI) is notable for a lack of high-quality clinical evidence. Here, we offer …